KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Notes Payables (2016 - 2024)

LifeMD (LFMD) has disclosed Notes Payables for 12 consecutive years, with $13020.0 as the latest value for Q2 2024.

  • For the quarter ending Q2 2024, Notes Payables fell 98.23% year-over-year to $13020.0, compared with a TTM value of $13020.0 through Jun 2024, down 98.23%, and an annual FY2023 reading of $327597.0, changed N/A over the prior year.
  • Notes Payables was $13020.0 for Q2 2024 at LifeMD, down from $115907.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $315.0 million in Q3 2023 and bottomed at $13020.0 in Q2 2024.
  • Average Notes Payables over 5 years is $21.6 million, with a median of $600424.0 recorded in 2020.
  • The sharpest move saw Notes Payables soared 2774.59% in 2023, then crashed 98.23% in 2024.
  • Year by year, Notes Payables stood at $779132.0 in 2020, then tumbled by 91.86% to $63400.0 in 2021, then changed by 0.0% to $63400.0 in 2022, then skyrocketed by 416.71% to $327597.0 in 2023, then plummeted by 96.03% to $13020.0 in 2024.
  • Business Quant data shows Notes Payables for LFMD at $13020.0 in Q2 2024, $115907.0 in Q1 2024, and $327597.0 in Q4 2023.